Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

InspireMD (NSPR) Cost of Revenue (2016 - 2025)

InspireMD (NSPR) has 16 years of Cost of Revenue data on record, last reported at $8.6 million in Q3 2025.

  • For Q3 2025, Cost of Revenue rose 485.05% year-over-year to $8.6 million; the TTM value through Sep 2025 reached $13.4 million, up 176.03%, while the annual FY2024 figure was $6.1 million, 57.02% up from the prior year.
  • Cost of Revenue reached $8.6 million in Q3 2025 per NSPR's latest filing, up from $1.5 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $8.6 million in Q3 2025 and bottomed at $636000.0 in Q2 2021.
  • Average Cost of Revenue over 5 years is $1.5 million, with a median of $1.1 million recorded in 2022.
  • Peak YoY movement for Cost of Revenue: skyrocketed 540.56% in 2021, then plummeted 33.49% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $1.6 million in 2021, then plummeted by 31.85% to $1.1 million in 2022, then tumbled by 33.49% to $723000.0 in 2023, then skyrocketed by 182.99% to $2.0 million in 2024, then soared by 320.92% to $8.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $8.6 million in Q3 2025, $1.5 million in Q2 2025, and $1.2 million in Q1 2025.